Chryseobacterium taklimakanense

(aka Planobacterium taklimakanense)

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Chryseobacterium taklimakanense, (aka Planobacterium taklimakanense), is a Gram-negative, non-spore-forming, facultatively anaerobic, motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 41.5%. Chryseobacterium taklimakanense is probably a rare gut coloniser. (Kim2016; Peng2009)



  • This organism has been recovered from desert soil, China. Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.
    • GENERAL CHARACTERISTICS (Kim2016); (Peng2009);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin; casein; gelatin; starch;
  • 🧂
  • Salt tolerance:
  • tolerates 0-2% salt; tolerates 3% salt; Grows optimally with 0% salt.
  • pH
  • Acidity tolerance:
  • tolerates pH 6.0; tolerates pH 12; Grows optimally at pH 7-8.
  • 🌡
  • Temperature tolerance:
  • grows at 18℃; grows at 37℃; doesn't grow at 41℃; Grows optimally at 30℃.
  • H+
  • Acid from carbohydrates usually produced:
  • glucose; mannose; aesculin; glycogen; starch; maltose; melibiose;
  • ⥅
  • Substrates assimilated or utilised:
  • L-arabinose; cellubiose; dextrin; gluconate; gentiobiose; glucose; glycogen; maltose; trehalose; D-turanose; alanine; aspartate; glutamate; leucine; ornithine; proline; serine; threonine; citrate; DL-lactate; 2,3-butanediol; glucose-1-phosphate; glutamine; L-asparagine; alaninamide; α-ketovalerate; α-ketobutyrate; 2-hydroxybutyrate; methyl succinate; methyl pyruvate; thymidine; uridine; inosine; D-glucose-6-phosphate; D-glucosaminic acid; urocanic acid;
  • Active enzymes:
  • alkaline phosphatase; acid phosphatase; catalase; chymotrypsin; cystine arylamidase; esterase C4; esterase lipase C8; α-glucosidase; Leu arylamidase; oxidase; phosphoamidase; Val arylamidase; naphthol-ASBI-P;
    • SPECIAL FEATURES (Kim2016); (Peng2009);
    Character Response
  • ✓
  • Metabolites produced:
  • indole;
  • ✗
  • Metabolites not produced:
  • H₂S;
  • ✓
  • VP test:
  • active
  • ✗
  • Haemolysis:
  • absent
  • ✗
  • Nitrate:
  • not reduced
    • RESPONSE TO ANTIBIOTICS (Kim2016); (Peng2009);
    Class Active Resistant
  • Penicillins:
  • amoxicillin; imipenem; piperacillin;
  • ampicillin; penicillin;
  • Cephalosporins:
  • cefalexin; cefazolin; cefixime; cefoperazone; cefotaxime; ceftizoxime; cefuroxime;
  • cefoxitin;
  • Macrolides:
  • azithromycin;
  • erythromycin;
  • Tetracyclines:
  • tetracycline;
  • doxycycline;
  • Quinolines:
  • levofloxacin; norfloxacin; ofloxacin;
  • Aminoglycosides:
  • gentamicin; kanamycin; neomycin; spectinomycin; streptomycin;
  • amikacin; tobramycin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • chloramphenicol; nitrofurantoin;
  • Vancomycins:
  • vancomycin; teicoplanin;
  • Miscellaneous antibiotics:
  • clindamycin; lincomycin; novobiocin;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Bacteroidetes Class:  Flavobacteriia Order:  Flavobacteriales Family:  Weeksellaceae Genus:  Chryseobacterium Alt. name:  Planobacterium taklimakanense Gram stain:  neg O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Swimming Morphology:  Rod
    Health:  Unknown
    Source:  desert soil, China
    DNA G+C(%):  41.5
    Opt. T:  30℃
    Low T(℃):  18(+)
    Mid T(℃):  37(+)
    High T(℃):  41(neg)
    NaCl 0.5-2%:  0-2(+)
    NaCl 3-5%:  3(+)
    Opt. pH:  7-8
    pH 6.0-8.0:  6.0(+)
    pH >8:  12(+)
    		Aesculin:  + Urea:  neg Gelatin:  + Starch:  + Casein:  + Agar:  neg Chitin:  neg Tyrosine:  neg Tween:  20(neg) 80(neg)
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    L-Arabinose:  neg Fructose:  neg Glucose:  + Mannose:  + Xylose:  neg Lactose:  neg Maltose:  + Melibiose:  + Sucrose:  neg Trehalose:  neg Aesculin:  + Glycogen:  + Starch:  + Mannitol:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    L-Arabinose:  + Glucose:  + Cellubiose:  + Gentiobiose:  + Maltose:  + D-Turanose:  + Trehalose:  + Dextrin:  + Gluconate:  + Glycogen:  + Ala:  + Asp:  + Glu:  + Leu:  + Orn:  + Pro:  + Ser:  + Thr:  + Citrate:  + DL-Lactate:  +
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  + Catalase:  + Urease:  neg α-Galactosidase:  neg β-Galactosidase:  neg α-Glucosidase:  + ArgDH:  neg Chymotrypsin:  + LysDC:  neg OrnDC:  neg Trypsin:  neg TrpAA:  neg CystineAA:  + LeuAA:  + ValAA:  + AlkalineP:  + AcidP:  + Esterase(C4):  + EstLip(C8):  + Phosphoamidase:  +
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		H2S:  neg Indole:  +
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  S(10; disc)
    ampicillin:  R(10; disc)
    penicillin:  R(10U)
    piperacillin:  S(100; disc)
    imipenem:  S(10; disc)
    cefalexin:  S(30; disc)
    cefazolin:  S(30; disc)
    cefixime:  S(5; disc)
    cefoperazone:  S(75; disc)
    cefotaxime:  S(30; disc)
    cefoxitin:  R(30; disc)
    ceftizoxime:  S(30; disc)
    cefuroxime:  S(30; disc)
    amikacin:  R(30; disc)
    gentamicin:  S(10; disc)
    kanamycin:  S(30; disc)
    neomycin:  S(30; disc)
    spectinomycin:  S(100; disc)
    streptomycin:  S(10; disc)
    tobramycin:  R(10; disc)
    azithromycin:  S(15; disc)
    erythromycin:  R(15; disc)
    levofloxacin:  S(5; disc)
    norfloxacin:  S(10; disc)
    ofloxacin:  S(5; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    doxycycline:  R(30; disc)
    tetracycline:  S(30; disc)
    teicoplanin:  S(30; disc)
    vancomycin:  S(30; disc)
    rifampicin:  S(5; disc)
    chloramphenicol:  S(30; disc)
    nitrofurantoin:  S(300; disc)
    clindamycin:  S(2; disc)
    lincomycin:  S(2; disc)
    novobiocin:  S(30; disc)

    References

    SPECIFIC REFERENCES FOR CHRYSEOBACTERIUM TAKLIMAKANENSE
  • Holmes2013 - DNA-DNA hybridization study of strains of Chryseobacterium, Elizabethkingia and Empedobacter and of other usually indole-producing non-fermenters of CDC groups IIc, IIe, IIh and IIi, mostly from human clinical sources, and proposals of Chryseobacterium bernardetii sp. nov., Chryseobacterium carnis sp. nov., Chryseobacterium lactis sp. nov., Chryseobacterium nakagawai sp. nov. and Chryseobacterium taklimakanense comb. nov.
  • Kim2016 - Chryseobacterium frigidum sp. nov., isolated from high-Arctic tundra soil, and emended descriptions of Chryseobacterium bernardetii and Chryseobacterium taklimakanense.
  • Peng2009 - Planobacterium taklimakanense gen. nov., sp. nov., a member of the family Flavobacteriaceae that exhibits swimming motility, isolated from desert soil.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR CHRYSEOBACTERIUM TAKLIMAKANENSE
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................
    • Added: February 09, 2022